Literature DB >> 8804531

Molecular diversity of peptidomimetics: approaches to the solid-phase synthesis of peptidosulfonamides.

D B de Bont1, W J Moree, R M Liskamp.   

Abstract

In order to use the potential molecular diversity of the peptidosulfonamide peptidomimetics ultimately in libraries, approaches towards the solid-phase synthesis of peptidosulfonamides are a prerequisite. It is shown that peptidosulfonamides can be synthesized by solid-phase synthesis methods using either a Merrifield or a Tentagel resin. Better and more reproducible results are obtained using the latter resin. The possibility to prepare cyclic peptidosulfonamides was illustrated by the synthesis of cyclo-phenylalanyl psi[CH2S(O)2N]-glycine. However, translation of synthesis of peptidosulfonamides in solution to a solid-phase method was rather laborious and still requires careful optimization.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8804531     DOI: 10.1016/0968-0896(96)00061-2

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  3 in total

1.  Automated synthesis of a 184-member library of thiadiazepan-1,1-dioxide-4-ones.

Authors:  Erik Fenster; Toby R Long; Qin Zang; David Hill; Benjamin Neuenswander; Gerald H Lushington; Aihua Zhou; Conrad Santini; Paul R Hanson
Journal:  ACS Comb Sci       Date:  2011-02-10       Impact factor: 3.784

2.  Synthesis and activity of endomorphin-2 and morphiceptin analogues with proline surrogates in position 2.

Authors:  Cesare Giordano; Anna Sansone; Annalisa Masi; Gino Lucente; Pasqualina Punzi; Adriano Mollica; Francesco Pinnen; Federica Feliciani; Ivana Cacciatore; Peg Davis; Josephine Lai; Shou-Wu Ma; Frank Porreca; Victor Hruby
Journal:  Eur J Med Chem       Date:  2010-07-21       Impact factor: 6.514

Review 3.  Peptide transformation leading to peptide-peptidosulfonamide hybrids and oligo peptidosulfonamides.

Authors:  Rob M J Liskamp; John A W Kruijtzer
Journal:  Mol Divers       Date:  2004       Impact factor: 2.943

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.